NCT01602406
- Conditions
- Advanced HER2-positive Breast Cancer or Gastric Cancer, Digestive System Diseases, Digestive System Neoplasms, +6 more
- Locations
-
- Novartis Investigative Site Boston, Massachusetts, United States
- Novartis Investigative Site Chapel Hill, North Carolina, United States
- Novartis Investigative Site Philadelphia, Pennsylvania, United States
- Novartis Investigative Site Wilrijk, Belgium